blindness with tirzepatide Vision loss risks in patients using popular GLP-1 medications raise concerns Ozempic Blindness: Is There a

Always consult a qualified healthcare professional before beginning any health-related research or experimentation

Learn more: #Pharma #ValueChains To view or add a comment, sign in Balancing GLP-1 Quality With Demand: A Live Discussion on the Future of Manufacturing and Scale The GLP-1 market is projected to nearly triple by 2030, reaching $156.7 billion globally, a growth trajectory that brings both opportunity and risk

By using less of the medicine, people can try to avoid the bad side effects while still getting some of the good effects, like losing weight or staying healthy

That's why we're proud to support conversations that share practical insights and inspiring perspectives on people, performance and leadership

(2004, Nature) : demonstration that Thymosin -4 promotes cardiomyocyte survival and new vessel formation after myocardial infarction in mice Phase II trials on volunteers (Regenerx Biopharmaceuticals) : accelerated corneal and cutaneous healing Philp et al